FundedIQ

Recently Funded Biotechnology, Healthcare & Pharmaceuticals Startups

Updated Sep 2026

FundedIQ tracks 16 funded Biotechnology, Healthcare & Pharmaceuticals startups, with their funding rounds, amounts, investors, industries, locations and company details. This page provides an overview of the Biotechnology, Healthcare & Pharmaceuticals startup funding landscape, along with the 16 most recently funded Biotechnology, Healthcare & Pharmaceuticals startups.

The median disclosed round is $15M, with the middle half of rounds falling between $5.3M and $67M. Cambridge and Berkeley hold the deepest concentrations of these companies. Biotechnology, Healthcare & Pharmaceuticals startups closed 17 funding rounds over the last 24 months, 17 of them in the last 12 months, and raised $544M in disclosed capital.

Concentration in Cambridge and Berkeley marks a sector of lean teams. These small headcounts indicate early stage operations where founders maintain tight control over procurement. Such profiles attract partners who can scale with a startup. The heavy presence of United States and United Kingdom firms creates a predictable geographic target for regional service providers.

Biotechnology, Healthcare & Pharmaceuticals funded startup statistics

Funded Biotechnology, Healthcare & Pharmaceuticals startups
16
tracked in the database
Funding rounds, last 12 months
17
17 over 24 months
Disclosed capital raised, 24 months
$544M
13 of 17 rounds disclosed an amount
Median round size
$15M
middle half $5.3M to $67M

Most recent funding round on record: May 2026.

16 most recently funded Biotechnology, Healthcare & Pharmaceuticals startups

16 shown

Ordered by the date of the latest funding round. Each row gives the company, its location and industry, what it does, the stage and date of that round, and the disclosed amount.

C
South San Francisco, United States · Biotechnology, Healthcare, Pharmaceuticals
Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific…
Series Unknown ·
Undisclosed
R
Syracuse, United States · Biotechnology, Healthcare, Pharmaceuticals
Repair Biotechnologies is a biotechnology company developing therapies based on the cholesterol-degrading…
Venture - Series Unknown ·
$5.3M
V
Lyon, France · Biotechnology, Healthcare, Pharmaceuticals
Ventuno Biotech is a biotech company that is developing innovative cancer therapies.
Seed ·
$2.3M
S
Boston, United States · Biotechnology, Healthcare, Pharmaceuticals
Skeletalis develops precision medicines targeting bone loss to treat osteoporosis and prevent fractures…
Seed ·
$8.0M
T
Cambridge, United Kingdom · Biotechnology, Healthcare, Pharmaceuticals
T-Therapeutics is a next-generation T cell receptor (TCR) company spun off from the University of Cambridge.
Series A ·
$32M
A
Berkeley, United States · Biotechnology, Healthcare, Pharmaceuticals
Azalea Therapeutics is a biotechnology company with a primary focus on developing cancer immunotherapies.
Series A ·
$65M
B
Biotechnology, Healthcare, Pharmaceuticals
Braveheart Bio is a clinical-stage biotechnology company focused on developing precision therapies in the…
Series A ·
$185M
Z
Cambridge, United States · Biotechnology, Healthcare, Pharmaceuticals
Zag Bio is a biotechnology company that designs thymus-targeting bifunctional antibody medicines to treat and…
Series A ·
$80M
E
Eliksa Therapeutics
Doylestown, United States · Biotechnology, Healthcare, Pharmaceuticals
Eliksa Therapeutics is a biotechnology company that develops regenerative medicine.
Venture - Series Unknown ·
Undisclosed
A
Donostia-San Sebastián, Spain · Biotechnology, Healthcare, Pharmaceuticals
Adaptam Therapeutics is at the forefront of next-generation cancer immunotherapies
Pre-Seed ·
$3.5M
I
Immunofoco
Shanghai, China · Biotechnology, Healthcare, Pharmaceuticals
Immunofoco is a biotechnology company that specializes in immune cell drugs for solid tumors patients.
Series B ·
Undisclosed
E
Palo Alto, United States · Biotechnology, Healthcare, Pharmaceuticals
Excellergy develops portfolio of trifunctional effector cell response inhibitors (ECRIs) to combat severe…
Series A ·
$70M
C
Natick, United States · Biotechnology, Healthcare, Pharmaceuticals
Curadel Surgical Innovations oversees the complete process of Curadel's FLARE contrast agents for…
Venture - Series Unknown ·
$15M
N
Nionyx Bio
New York, United States · Biotechnology, Healthcare, Pharmaceuticals
Nionyx Bio builds AAV-based gene therapies to address some of the most potent kidney genetic diseases.
Seed ·
Undisclosed
A
Cambridge, United Kingdom · Biotechnology, Healthcare, Pharmaceuticals
Treating the seeds of cancer
Seed ·
$4.7M
N
London, United Kingdom · Biotechnology, Healthcare, Pharmaceuticals
Nuclide Therapeutics provides radiopharmaceutical medicines that combine nuclear medicine and biotechnology.
Seed ·
$6.7M

Countries with the most funded Biotechnology, Healthcare & Pharmaceuticals startups

Where funded Biotechnology, Healthcare & Pharmaceuticals startups are headquartered, by the country on the company record.

Where are funded Biotechnology, Healthcare & Pharmaceuticals startups located?

Where funded Biotechnology, Healthcare & Pharmaceuticals startups are based, by the city on the company record.

Funding stages of funded Biotechnology, Healthcare & Pharmaceuticals startups

How the last 24 months of funding rounds for funded Biotechnology, Healthcare & Pharmaceuticals startups break down by stage.

Stage
Rounds, last 24 months

A further 4 rounds in this period were announced without a stage label and are not ranked above.

About the FundedIQ Biotechnology, Healthcare & Pharmaceuticals startup funding data

FundedIQ tracks announced startup funding rounds and organises them by company, funding date, stage, amount, industry, location and investor. The dataset is refreshed weekly, and new rounds are normalised and de-duplicated before they are published, so the same round reported twice on different dates is recorded once.

Figures on this page cover the 16 funded Biotechnology, Healthcare & Pharmaceuticals startups currently tracked. Round counts, capital totals and the median round are computed over a trailing 24 months. Rounds whose amount was not disclosed (4 of 17 in that period) are counted as rounds but excluded from capital totals and from the median. The most recent round on record for funded Biotechnology, Healthcare & Pharmaceuticals startups is dated May 2026.

The table above shows the 16 most recently funded companies. Full funding histories, investor lists and founder contacts across the whole dataset open on a FundedIQ plan.

Frequently asked questions

How many funded Biotechnology, Healthcare & Pharmaceuticals startups are there?

FundedIQ tracks 16 funded Biotechnology, Healthcare & Pharmaceuticals startups. This page lists the 16 most recently funded of them, ordered by the date of their latest round, and the full set is available on a FundedIQ plan.

How much funding have Biotechnology, Healthcare & Pharmaceuticals startups raised?

Biotechnology, Healthcare & Pharmaceuticals startups tracked by FundedIQ have raised $544M in disclosed capital across 17 funding rounds over the last 24 months, including 17 rounds in the last 12 months. 13 of those 17 rounds disclosed an amount; undisclosed rounds are excluded from the capital total.

Which countries have the most funded Biotechnology, Healthcare & Pharmaceuticals startups?

United States leads with 9 companies, ahead of United Kingdom (3), China (1) and France (1).

Which cities have the most funded Biotechnology, Healthcare & Pharmaceuticals startups?

Cambridge leads with 3 companies, then Berkeley (1), Boston (1) and Donostia-San Sebastián (1).

What is a typical funding round size for Biotechnology, Healthcare & Pharmaceuticals startups?

The median disclosed round over the last 24 months is $15M, and the middle half of rounds fall between $5.3M and $67M. Round sizes vary widely by stage, so the seed and later-stage bands sit well either side of that figure.

What is the most common funding stage for Biotechnology, Healthcare & Pharmaceuticals startups?

Seed is the most common labelled stage, with 5 rounds in the last 24 months, ahead of Series A (5) and Series B (2). A further 4 rounds were announced without a stage label and are not counted here.

How often is the Biotechnology, Healthcare & Pharmaceuticals startup funding data updated?

The dataset is refreshed weekly. New rounds are normalised and de-duplicated before they are published, and the most recent round currently on record for funded Biotechnology, Healthcare & Pharmaceuticals startups is dated May 2026. Counts and totals on this page are recomputed on every refresh.

Related listings

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.